Overview of the Federal Probes into Medical School Admissions
The U.S. Department of Justice (DOJ) under the Trump administration has launched investigations into potential race discrimination in admissions at three prominent medical schools: Stanford University School of Medicine, Ohio State University College of Medicine, and University of California, San Diego (UCSD) School of Medicine. Announced on March 25, 2026, these probes mark an escalation in the federal government's scrutiny of higher education practices following the Supreme Court's 2023 ruling in Students for Fair Admissions (SFFA) v. Harvard, which prohibited race-conscious admissions.
Assistant Attorney General for Civil Rights Harmeet K. Dhillon notified the schools via letters, demanding comprehensive admissions data from the past seven years. The move reflects the administration's commitment to enforcing colorblind admissions policies at institutions receiving federal funds, amid ongoing debates about diversity, equity, and inclusion (DEI) initiatives in medical education.
Background: The Supreme Court's Landmark SFFA Ruling
In June 2023, the Supreme Court ruled 6-3 that race-based affirmative action in college admissions violates the Equal Protection Clause of the 14th Amendment and Title VI of the Civil Rights Act of 1964. Chief Justice John Roberts wrote that universities could no longer use race as a 'plus factor' or stereotype applicants based on racial groups. The decision ended decades of race-conscious policies aimed at increasing underrepresented minority (URM) enrollment.
Medical schools, like undergraduate programs, shifted to race-neutral approaches such as holistic review, which considers life experiences, socioeconomic background, and adversity indices. However, critics argue some schools use proxies like essays on 'lived experiences' to indirectly favor certain racial groups, prompting federal intervention.
The Targeted Institutions and Their Admissions Profiles
Stanford University School of Medicine
Stanford admits about 119 students annually. Its 2025-26 class is 13% Black, higher than the national average of 8%. The school emphasizes holistic review post-SFFA, evaluating applicants' resilience and community service. It received $575 million in NIH funding in 2025.
Ohio State University College of Medicine
With 211 incoming students, OSU's demographics mirror national figures: roughly 42% white, 28% Asian. It states full compliance with federal laws and uses multiple mini-interviews (MMIs) in its process. NIH funding: $210 million in 2025.
UC San Diego School of Medicine
UCSD enrolls 140 students yearly, with 6% Black students, elevated Asian representation, and fewer whites than average. As part of the UC system—already under DOJ scrutiny—it commits to fair processes. NIH funding: $427 million.
Data Demands and Privacy Concerns
The DOJ requests applicant data including MCAT scores, GPAs, home ZIP codes, alumni/donor ties, internal DEI communications, and pharma correspondence. Deadline: April 24, 2026. Small class sizes raise privacy risks under FERPA, potentially identifying individuals. Schools must balance compliance with student protections.
Legal Framework and Trump Administration's Approach
Investigations invoke Title VI and 28 CFR Part 42, Subpart C, allowing proactive probes of federally funded entities. An August 2025 executive order mandates admissions transparency, and AG Pam Bondi's guidance prohibits race preferences. This builds on prior actions like probes at Harvard and UCLA.
Supporters view it as restoring meritocracy; opponents fear it chills diversity efforts. For more on federal funding leverage, see the NSF report on research support.
Schools' Responses and Compliance Stances
Stanford declined comment. OSU affirmed regulatory compliance. UCSD is reviewing the notice, pledging adherence to anti-discrimination laws. All emphasize race-neutral holistic reviews post-SFFA.
Diversity Trends in Medical Schools Post-SFFA
AAMC data shows MD matriculants: 42% white, 28% Asian, 8% Black (2025-26). Post-2023, Black enrollment fell 11.6%, Hispanic 10.8% in 2024-25, while white/Asian rose. DO programs show persistent URM underrepresentation. See AAMC's FACTS tables for details.
MCAT and GPA Disparities by Race/Ethnicity
AAMC 2025-26 data reveals gaps: Asian applicants average MCAT 508.8, GPA 3.72; White 507.8/3.71; Hispanic/Latino lower, Black/African American lowest around 504/3.4. Matriculants show similar patterns, fueling debates on merit vs. opportunity.
- Asians/Whites often exceed thresholds despite competition.
- URMs face barriers like K-12 preparation, socioeconomic factors.
Stakeholder Perspectives
AAMC advocates holistic, race-neutral strategies for equity. AMA warns diversity aids patient outcomes. Critics like Dhillon argue DEI discriminates against high-achieving Asians/Whites. Supporters of probes cite SFFA compliance. X posts trend with #MeritNotRace. JAMA study links post-SFFA declines to equity threats.
Implications for Medical Education and Physician Workforce
NIH funds at risk could disrupt research. Diverse physicians improve care for underserved populations, reducing disparities. Race-neutral tools like socioeconomic proxies (e.g., UC Davis model) tripled URMs without race.
Race-Neutral Alternatives and Holistic Review
Schools use adversity scores, top-percent plans, community service. UC Davis' model succeeded pre-SFFA. Challenges: ensuring no proxies violate law.
Photo by Margaret Giatras on Unsplash
Future Outlook and Policy Recommendations
Probes may lead to lawsuits, policy shifts. Medical schools eye race-neutral innovations; Congress could clarify funding ties. Balancing merit, diversity essential for workforce addressing U.S. demographics (projected 2045 majority-minority).
Explore faculty positions at these institutions via AcademicJobs.com faculty jobs.